Showing results (31-40 of 270) with videos related to
Sort By:
Pageof 27
QJM : Monthly Journal of the Association of Physicians|August 10, 2005
B-type natriuretic peptide: a simple new test to identify coronary artery disease?A D Struthers, J DaviesJournal of Human Hypertension|February 1, 1989
Sympathoadrenal responses during bradycardia-hypotension associated with combined infusion of atrial natriuretic factor and prostaglandin E2J McMurray, A D StruthersBritish Journal of Hospital Medicine|July 1, 1988
Significance of atrial natriuretic factor in chronic heart failureJ McMurray, A D StruthersThe Journal of Pharmacy and Pharmacology|February 1, 1987
Sodium nitroprusside: pharmacological aspects of its interaction with hydroxocobalamin and thiosulphateD S Hewick, A R Butler, C Glidewell, et al.European Heart Journal|February 3, 1998
Can drug effects on mortality in heart failure be predicted by any surrogate measure?K M Yee, A D StruthersCirculation|February 15, 2000
Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failureC A Farquharson, A D StruthersPostgraduate Medical Journal|January 1, 1983
The haemodynamic effects of labetalol under conditions of increased levels of circulating catecholaminesA D Struthers, J L ReidJournal of Cardiovascular Pharmacology|January 1, 1997
The practical assessment of compliance with ACE-inhibitor therapy--a novel approachR J MacFadyen, A D StruthersHeart (British Cardiac Society)|May 17, 2005
Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failureA D Gavin, A D StruthersBritish Journal of Clinical Pharmacology|April 1, 1994
Interactive effects of indomethacin, angiotensin II and frusemide on renal haemodynamics and natriuresis in manJ G Motwani, A D StruthersPageof 27